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Summary Use of ofﬁcial health services often remains low despite great efforts to improve
quality of care. Are informal treatments responsible for keeping a number of patients away from
standard care, and if so, why? Through a questionnaire survey with proportional cluster samples,
we studied the case histories of 952 children in Bandiagara and Sikasso areas of Mali. Most
children with reported uncomplicated malaria were ﬁrst treated at home (87%) with modern
medicines alone (40%), a mixture of modern and traditional treatments (33%), or traditional
treatment alone (27%). For severe episodes (224 cases), a traditional treatment alone was used
in 50% of the cases. Clinical recovery after uncomplicated malaria was above 98% with any
type of treatment. For presumed severe malaria, the global mortality rate was 17%; it was not
correlated with the type of treatment used (traditional or modern, at home or elsewhere). In
the study areas, informal treatments divert a high proportion of patients away from ofﬁcial
health services. Patients’ experience that outcome after standard therapeutic itineraries is
not better than after alternative care may help to explain low use of ofﬁcial health services.
We need to study whether some traditional treatments available in remote villages should be
considered real, recommendable ﬁrst aid.
© 2005 Royal Society of Tropical Medicine and Hygiene. Published by Elsevier Ltd. All rights
reserved.
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1. Introduction
In Mali, attendance at community health centres often
remains poor despite great efforts to improve quality of
care. Several explanations have been proposed: patients’
lack of resources, long distances from home to the nearest
health centre, poor health services management (Huissoud
et al., 2004). This situation seems common in Africa, and has
been related to the fact that modernmedicines often remain
problematic in remote areas: even when apparently avail-
able, they are often unaffordable, misused or even coun-
terfeit (Basco, 2004; Dossou-Yovo et al., 2001; Tumwesigire
and Watson, 2002).
From discussions with community representatives, we
suspected that another reason could partly explain low
attendance in community health centres: self-medication
and traditional medicines might keep patients away from
ofﬁcial health services. We were able to test this hypothesis
through a case study: an enquiry about therapeutic prac-
tices for children with presumed malaria, uncomplicated or
severe, in remote rural areas.
2. Methods
2.1. Study design
T
D
R
g
t
d
c
m
2
T
e
v
t
d
(
o
w
s
a
s
t
i
w
l
p
p
2
2
T
l
health area of Kendie´ is located in Bandiagara region, 45 km
away from the nearest city and hospital of Bandiagara. The
vast majority of inhabitants are farmers. In Kendie´ there
is a community health centre and there is also a tradi-
tional healers’ association. The health area of Finkolo AC
is situated in Sikasso region, 40 km away from the region’s
capital, Sikasso, on the road to Burkina Faso. In Finkolo
there is a community health centre. In the area there are
many traditional healers, who are not organized in an asso-
ciation. Agriculture is the main economic activity in this
region.
2.4. Population
A questionnaire was administered in households at the end
of the rainy season (high transmission period). As it is usually
impossible to have just one person answering a question-
naire in a village, every interview was set up as a mini-focus
group (with the mother, and a few family members) about
one particular patient (age 0—16 years) and disease episode
with a recall period of 2 weeks for an uncomplicated episode
and 6 months for severe malaria. Proportional cluster sam-
ples were drawn according to the population census and
continuous civil records of the areas (Bennett et al., 1991).
Sample size was decided on the basis of the expected preva-
lence of malaria in the area, in order to ﬁnd at least 600
uncomplicated malaria cases.
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chis work was a collaborative programme between the
epartment of Traditional Medicine (National Institute of
esearch in Public Health, Mali) and Antenna Technolo-
ies (Geneva, Switzerland). A population-based retrospec-
ive survey, with questionnaires, was conducted in two rural
istricts in southern and eastern Mali. Field research was
omplemented by laboratory screening of the local treat-
ents correlated with the best clinical outcome.
.2. Deﬁnition of malaria
wo perspectives were used and compared: popular knowl-
dge, which is the basis for therapeutic decisions at the
illage level, and community health centre clinical deﬁni-
ions. It was already known that in Mali popular knowledge
istinguishes between uncomplicated and severe malaria
Traore´, 1999). The clinical deﬁnition of malaria was based
n national malaria policy; in community health centres,
here laboratory tests are not available, any fever is con-
idered to be malaria unless there is another obvious cause
nd any fever with coma or convulsion during the rainy sea-
on or soon after is treated as severe malaria. Recent studies
end to increase reliance on clinical deﬁnitions of malaria,
n showing that Plasmodium falciparum parasitaemia is not
ell correlated with actual disease (some patients have
ow parasitaemia and severe symptoms; others have high
arasitaemia with no clinical disease) except for very high
arasitaemias (Delley et al., 2000; Von Seidlein et al.,
002).
.3. Study sites
he study areas were chosen in view of their relative iso-
ation (long distances to the modern health centre). The.5. Data collection
s this study was, to our knowledge, the ﬁrst of its kind (i.e.
ith this attention to outcome and disease severity), we had
o construct and validate an original questionnaire. Several
rafts were revised by malaria researchers, public health
pecialists, pharmacists, anthropologists, local health work-
rs, malaria patients and parents. Then the questionnaire
as pre-tested in 34 houses, with similar ethnic composi-
ion, adjacent to the study areas. Data were collected in
ecember 2002—January 2003.
.6. Data analyses
ata were analysed with EpiInfo 6 software (CDC, Atlanta,
A, USA), with 2 and Fisher’s exact tests for discrete vari-
bles, and Kruskall-Wallis test for means.
.7. Laboratory analyses
amples of plants with the best clinical outcomes, deter-
ined by analysis of correlation between outcome and
reatments (Graz et al., 2005) were collected in the
ikasso region. The plant parts used locally (e.g. stems and
eaves) were extracted with water and organic solvents
dichloromethane, methanol and ethanol) at the Depart-
ent of Traditional Medicine in Bamako. Extracts were
reeze-dried and used for biological tests.
The extracts were tested for their IC50 (concentration
nhibiting 50% of parasite growth) on cultured chloroquine-
esistant P. falciparum (strain K1, stage IEF, Swiss Tropical
nstitute, Basel, Switzerland). In these tests, the control was
hloroquine.
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2.8. Ethical aspects
The study was accepted by the Malian ethical committee.
It was conducted in retrospect because we were also inter-
ested in severe malaria and its actual local treatments.
3. Results
Information to the local people and respect of traditional
etiquette resulted in a good acceptance of the survey: from
the 483 households in the Bandiagara region and 469 house-
holds in the Sikasso region, nobody refused to answer the
questionnaire, so the global response rate was 100%; some
questions, however, were not answered by 100% of respon-
dents, as will be mentioned below.
Unless otherwise mentioned, results presented here are
derived from pooled records from both regions (Finkolo and
Kendie´ areas). Similarities in sample sizes and results justify
such pooling.
Local designations of uncomplicated and severe malaria
were in fairly close agreement with deﬁnitions based on clin-
ical criteria and used in local dispensaries and health centres
(86% agreement in Bandiagara, 98% in Sikasso region), the
latter being used for correlation analyses below.
As shown in Figure 1, self-medication (traditional or mod-
ern medicine, see below) as ﬁrst treatment was the rule for
uncomplicated malaria (87% of 719 cases), with increased
Figure 1 Health services used for ﬁrst treatment (1st Rx)
and second treatment (2nd Rx) in cases of (A) uncomplicated
malaria and (B) severe malaria.
lowed by oral administration as soon as possible; fumigation
and inhalation were often reported in case of severe malaria
(35%) as a way of giving treatment to a comatose or convuls-
ing child, as well as massage with a plant-based ointment
(4%, others 2%).
The trend was towards less modern treatment with more
remoteness, which was statistically signiﬁcant in the case
of severe malaria in the Sikasso region: among those liv-
ing more than 15 km away from the PHC centre (63% of the
sample) more than half (54%) started with traditional treat-
ment only, compared with 33% among those living closer
(P = 0.04). Modern treatment was more often sought when a
motor vehicle was available in the household (alone or with
type of treatment
Severe malaria
1st Rx 2nd Rx
Modern only 54 (24) 29 (36)
Traditional only 111 (50) 40 (49)
Both 59 (26) 12 (15)
Total 224 (100) 81 (100)recourse to traditional healers and modern health centres
when a second treatment was sought. For severe malaria
(224 cases with a ﬁrst treatment, 84 with a second), 55%
started with self-medication, while visits to traditional heal-
ers were relatively frequent (32 vs. 4% for an uncomplicated
episode, P < 0.001). Modern health centres tended to receive
more demands for severe episodes (13 vs. 9% for an uncom-
plicated episode, P = 0.08).
In the case of uncomplicated malaria, more than 60% of
the patients received treatment at the ﬁrst symptoms. For
severe malaria, only 24% were treated before convulsions or
coma.
Table 1 shows that exclusive use of traditional medicine
as ﬁrst treatment was more common in severe malaria.
Exclusive use of traditional medicine was also the most fre-
quent second treatment, whatever the type of malaria. The
traditional medicines used were mainly medicinal plants
(91%), otherwise incantations and prayers (4%), or others
(3%). Patients with uncomplicated malaria that were treated
with medicinal plants took them orally and as a bath in 95%
of the cases (fumigation 4%, others 1%). For severe malaria
treated with plants, 59% of patients had baths, usually fol-
Table 1 Number and percentage of patients receiving each
Uncomplicated malaria
1st Rx 2nd Rx
Modern only, n (%) 294 (41) 44 (33)
Traditional only, n (%) 183 (25) 88 (66)
Both, n (%) 242 (34) 2 (1)
Total, n (%) 719 (100) 134 (100)
1st Rx: ﬁrst treatment; 2nd Rx: second treatment.
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Table 2 Progress of patients after different treatments
Treatment Cured Cured with
sequels
Death
Uncomplicated malaria
Modern only,
n (%)
218 (100) 0 (0) 0 (0)
Traditional
only, n (%)
144 (98) 1 (1) 2 (1)
Both, n (%) 326 (100) 0 (0) 0 (0)
Total 688 1 2
Severe malaria
Modern only,
n (%)
16 (70) 1 (4) 6 (26)
Traditional
only, n (%)
65 (82) 5 (6) 9 (11)
Both, n (%) 84 (76) 5 (5) 21 (19)
Total 165 11 36
traditional treatment, all cases: 73 vs. 66%, P = 0.02) and
when the mother had studied in the ‘madrasa’ or Koranic
school (85% sought modern treatment, vs. 67% among those
who had no schooling, P = 0.004). No relation was found
between the type of treatment used and the father’s profes-
sion and level of education, nor the number of other children
at home. Prices of treatment (in francs CFA: 1000CFA≈ £1
or D 0.8) were related to type of malaria (uncompli-
cated episode mean price = 504 FCFA; severe [whatever the
type of treatment used] = 1340 FCFA; P = 0.03) and type
of treatment (ﬁrst treatment traditional mean price = 200
FCFA; modern [whatever the type of malaria] = 830 FCFA;
P < 0.001).
As shown in Table 2, total recovery after uncomplicated
malaria was above 98% for any treatment. In the case of
severe malaria, the global death rate was 17%. Patient
progress did not statistically differ with different types of
treatment. For data missing on progress (2.2% of uncompli-
cated cases, 3.6% of severe cases, P = 0.2) types and places
of treatment were similar to the ones found in the total
sample, as well as socio-demographic data. Sequelae were
reported in 5% of severe cases and 0.5% of uncomplicated
cases.
None of the local treatments was correlated with poor
patient progress, but some were systematically associated
with clinical cure. Some of these were already known to be
active against P. falciparum. Six plants with activities not
mentioned in the scientiﬁc literature were investigated in
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4. Discussion
The objective of this study was to examine how and why
use of home- or village-based treatments may keep patients
away from ofﬁcial health services. For this, we studied ther-
apeutic practices and subsequent patient progress in pre-
sumed malaria episodes in remote areas.
Self-medication (modern drugs or traditional medicine)
was the most frequent type of ﬁrst treatment sought, even
for suspected severe malaria. For severe malaria, traditional
medicine was the only treatment used in half the cases.
After uncomplicated malaria, total recovery was above 98%
with any type of treatment. For severe malaria, the global
mortality rate was 17% and did not signiﬁcantly differ with
the type of treatment used. Some local products were sys-
tematically associated with good clinical outcome and found
to have medium to high in-vitro antiplasmodial activity.
Severity in itself was not a reason for seeking modern
health care: only 24% of patients with severe malaria chose
modern medicine as their ﬁrst option, whereas 41% of those
with uncomplicated malaria did so. One reason for this could
be that severe malaria is more often related to supernatu-
ral events (Berche, 1994). Another explanation could be the
perceived effectiveness of traditional medicine for severe
malaria and experience of high case-fatality rate in the hos-
pital.
The trend was towards fewer fatalities after traditional
treatment (11%) than after modern treatment (26%). One
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.1. In-vitro studies
rude extracts of the selected plants were obtained and
ested in the laboratory: all were found to have medium
o high antiplasmodial activity in chloroquine-resistant
. falciparum cultures. Four crude extracts displayed a
edium inhibitory concentration (IC50) smaller than 5l/ml:
pondias mombin, Opilia celtidifolia, Securinega virosa,
rgemone mexicana.xplanation might be that some of those considered as
uffering from severe malaria in our sample actually had
nother less fatal illness (the same applies to the 2% of
atalities observed after presumed uncomplicated malaria:
t might have been another disease). Uncomplicated malaria
ight have become severe, although in this case the patient
hould have been registered only once, as a severe case.
nother possible explanation is a certain degree of effec-
iveness of some local, traditional treatments. Even if they
re less effective than modern drugs in absolute terms, they
ould improve the prognosis of malaria patients because of
he shorter time lag between onset of the malaria episode
nd treatment. In other words, greater effectiveness of
are offered in modern health centres might be offset by
he fact that patients arrive there after a long journey in
more critical state. Such a hypothesis could be tested
ith a non-experimental design, for ethical reasons (Willcox
t al., 2004).
The plants found to have high activity against
hloroquine-resistant P. falciparum were not necessarily
escribed as such in the literature. Spondias mombin L.
Anacardiaceae) is a medium-sized tree bearing edible fruits
‘hog plums’), common in both South America and tropi-
al Africa. The bark and leaves are traditionally used for
isinfections (e.g. abscesses, caries, conjunctivitis). Anti-
erpetic tannins have been isolated and characterized from
his plant. Opilia celtidifolia (Guill. et Perr.) (Opiliaceae)
s either a small tree or a creeper reaching 8—10m and
estricted to tropical West Africa. The roots and leaves
re used to treat fever, inﬂuenza and intestinal worms.
are modern studies on this plant demonstrated its high
ontent in saponins and tannins. Argemone mexicana L.
Mexican poppy or prickly poppy) is a robust herbaceous
nnual, a member of the poppy family (Papaveraceae)
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(Arbonnier, 2002). This weed looks like a thistle, but its
yellow ﬂowers are characteristic of the Papaveraceae, as
is its abundant bright yellow latex. Typical chemical con-
stituents are benzophenanthridine alkaloids (among them
berberine, protopine and sanguinarine). Securinega virosa
(Roxb. ex Willd.) (Euphorbiaceae) is a 2—3m shrub common
in West Africa, but also in Australia and Asia. It has numer-
ous traditional uses, and its roots are frequently described
as soporiﬁc and analgesic, although its leaves are considered
a stimulant and an aphrodisiac. This plant has been studied
for trypanocidal activity.
Limitations of this study include the uncertainty created
by the controversial deﬁnition of malaria in areas where
diagnosis and therapeutic decisions must be performedwith-
out laboratory facilities. The fact that the diagnosis of
malaria, both severe and uncomplicated, is not by necessity
conﬁrmed greatly weakens the conclusions made. Deﬁni-
tions of malaria by traditional practitioners probably result
in over-diagnosis: in a study by Willcox et al. (unpublished)
of 245 patients diagnosed with ‘soumaya’ (considered equiv-
alent to uncomplicatedmalaria) by a traditional practitioner
in south Mali, 30 had no plasmodia in their blood and 118
had only a low parasitaemia (<2000 parasites/l), thus not
reaching commonly used criteria of malaria. Observation of
actual therapeutic itineraries along categories of ‘ﬁrst’ and
‘second’ treatments is very schematic and probably elicits
only part of the very complex process of health-care-seeking
behaviours. Data may be incomplete and biased, because
course of this study, of patients waking immediately after
an inhalation, may be an indication of product effect not
solely related to the parasite cycle. To determine physio-
logic activities would require speciﬁc research (for example
with animal models or healthy volunteers).
5. Conclusions
In the areas studied, self-medication and traditional
medicines for malaria divert a high proportion of patients
away from modern health centres, especially for severe
episodes. For the latter, case-fatality rates tend to be
lower after traditional home- or village-based treatments,
although without any statistically signiﬁcant difference. This
suggests that distance, poor quality service, or economic
barriers are not the only reasons why attendance to health
centres is poor, but also perceived effectiveness of alterna-
tive care. Rather than ignoring or suppressing this situation,
a pragmatic approach could be to study the potential effec-
tiveness of some home-care and whether local or regional
synergies between different health systems could improve
patient outcome.
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Gthey are based on memories of the past 6 months. Miss-
ing data on progress was probably due to the interviewer,
because it is unlikely that parents forgot the outcome of
their child’s disease. For dramatic events the recall errors
are probably small, but for details they can be important.
For severe malaria, recommendations are to bring the
sick child to the health centre as fast as possible. However,
travel is often difﬁcult, especially during the rainy season,
and health professionals attribute many of their treatment
failures to delayed access to modern treatment in the case
of severe malaria, as well as delayed or inappropriate treat-
ment in the case of uncomplicated malaria (Muller et al.,
2003; Noor et al., 2003). The ﬁrst few malaria episodes
are the most dangerous, because immunity to malaria rises
rapidly after a limited number of infections (Gupta et al.,
1999), so it seems important to study every potential way
of improving the care of young patients.
After this study, we suggest that the potential role of
traditional treatments for malaria should be further investi-
gated. To start with, a retrospective outcome and treatment
study seems very useful. Then one can search for new anti-
malarial molecules. But other interesting directions exist
as well: the development of new ‘medicaments tradition-
nels ame´liore´s’ (improved traditional medicines), which is a
national policy in Mali; and the study of potential recommen-
dations for home ﬁrst-aid treatments with local resources.
The study of physiological and immunomodulating actions of
traditional antimalarials also deserves more attention: some
local treatments could be found to act in a way that is not
antiparasitic as such. They might counterbalance metabolic
or haemodynamic disturbances that are life-threatening in
malaria; some products may correct hypoglycaemia or lac-
tic acidosis, improve capillary ﬂow, prevent convulsions,
or boost the immune response. Anecdotal reports in thecknowledgements
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